var data={"title":"Breast cellulitis and other skin disorders of the breast","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Breast cellulitis and other skin disorders of the breast</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/contributors\" class=\"contributor contributor_credentials\">J Michael Dixon, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/contributors\" class=\"contributor contributor_credentials\">Larry M Baddour, MD, FIDSA, FAHA</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/contributors\" class=\"contributor contributor_credentials\">Anees B Chagpar, MD, MSc, MA, MPH, MBA, FACS, FRCS(C)</a></dd><dd><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/contributors\" class=\"contributor contributor_credentials\">Daniel J Sexton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jun 20, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Breast cellulitis is a skin infection that occurs as a result of bacterial entry via breaches in the skin barrier. Issues related to breast cellulitis and other skin disorders of the breast will be reviewed here. Issues related to breast abscess and lactational mastitis are discussed separately, as are issues related to breast reconstruction. (See <a href=\"topic.htm?path=primary-breast-abscess\" class=\"medical medical_review\">&quot;Primary breast abscess&quot;</a> and <a href=\"topic.htm?path=lactational-mastitis\" class=\"medical medical_review\">&quot;Lactational mastitis&quot;</a> and <a href=\"topic.htm?path=overview-of-breast-reconstruction\" class=\"medical medical_review\">&quot;Overview of breast reconstruction&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H7390833\"><span class=\"h1\">BREAST CELLULITIS</span></p><p class=\"headingAnchor\" id=\"H3786583\"><span class=\"h2\">Epidemiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Breast cellulitis is relatively uncommon. A prospective study including 3762 patients evaluated in a dedicated breast center during a 14-month interval found that 0.6 percent presented with erythema of the breast and, of those 22 patients, only 2 had cellulitis [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/1\" class=\"abstract_t\">1</a>]. Among patients managed for breast cancer with breast-conserving surgery and radiation therapy, breast cellulitis occurs in 1 to 8 percent of patients [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/2-7\" class=\"abstract_t\">2-7</a>].</p><p>Risk factors for breast cellulitis include [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/1-5,7-9\" class=\"abstract_t\">1-5,7-9</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Breast conservation treatment for breast cancer (breast conserving surgery and radiation therapy)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Prior breast cellulitis or infection</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Breast surgery within previous 30 days (surgical site infection)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lactation</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Trauma (eg, bites, nipple piercing, tattoos)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lesions in breast skin (eg, eczema, intertrigo, dermatitis, epidermolysis bullosa)</p><p/><p>Risk factors for breast cellulitis complicating breast conserving surgery include hematoma formation, post-operative bruising, breast edema, large resected volume, and the need for multiple seroma aspiration [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/5\" class=\"abstract_t\">5</a>].</p><p class=\"headingAnchor\" id=\"H7047054\"><span class=\"h2\">Microbiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Beta-hemolytic <em>Streptococcus</em> is an important cause of breast cellulitis [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/3,9,10\" class=\"abstract_t\">3,9,10</a>]. Group B beta-hemolytic streptococci have a proclivity to produce soft tissue infections in the setting of venous <span class=\"nowrap\">and/or</span> lymphatic compromise [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/11\" class=\"abstract_t\">11</a>]; one case control study noted breast cancer was a risk factor for the development of group B beta-hemolytic streptococcal infection [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/12\" class=\"abstract_t\">12</a>].</p><p><em>Staphylococcus aureus</em>, including methicillin-resistant <em>S. aureus</em> (MRSA), can also be an important pathogen.</p><p class=\"headingAnchor\" id=\"H12681954\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Clinical manifestation of breast cellulitis include pain, diffuse erythema, tenderness, and warmth [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/2,4,5,8,13,14\" class=\"abstract_t\">2,4,5,8,13,14</a>]. Systemic symptoms such as fever or chills are uncommon, occurring in only 6 of 50 cases in one series [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/4\" class=\"abstract_t\">4</a>]. The physical examination of the breast demonstrates localized or diffuse erythema, edema, marked tenderness, and warmth. Axillary nodes can be enlarged and tender.</p><p class=\"headingAnchor\" id=\"H22190971\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of breast cellulitis is made based on clinical manifestations [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/6,15-20\" class=\"abstract_t\">6,15-20</a>]. The evaluation includes obtaining a clinical history to assess for trauma, underlying skin condition, breastfeeding, and previous breast surgery, breast cancer diagnosis, <span class=\"nowrap\">and/or</span> local radiation treatment. A breast examination should be performed to assess the extent of erythema and swelling as well as for presence of tender <span class=\"nowrap\">and/or</span> enlarged axillary lymph nodes.</p><p>No laboratory testing is required. Blood cultures are warranted in the setting of severe infection (eg, hemodynamic instability, progressive erythema) but are otherwise not routinely necessary.</p><p>Radiographic imaging is useful if there is clinical suspicion of an underlying fluid collection, abscess, malignancy, or if there is no clinical improvement within 48 hours of treatment with antibiotic therapy. Ultrasound may demonstrate skin edema; mammography may demonstrate mild skin thickening [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/21\" class=\"abstract_t\">21</a>]. Magnetic resonance imaging (MRI) may demonstrate skin thickening and separation or septation of subcutaneous adipose tissue [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/22\" class=\"abstract_t\">22</a>].</p><p class=\"headingAnchor\" id=\"H3786712\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Breast cellulitis must be distinguished from other inflammatory processes of the breast. Disruption of cutaneous lymphatics <span class=\"nowrap\">and/or</span> circulation in the absence of an infectious process, such as a malignancy or an inflammatory process, can lead to a diffuse pattern of erythema that mimics cellulitis [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/23-25\" class=\"abstract_t\">23-25</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Breast abscess &ndash; A breast abscess is a localized collection of pus in the breast tissue. Patients with breast abscess present with localized painful inflammation of the breast associated with fever and malaise, along with a fluctuant, tender, palpable mass. The diagnosis is based on clinical manifestations and ultrasonography. (See <a href=\"topic.htm?path=primary-breast-abscess\" class=\"medical medical_review\">&quot;Primary breast abscess&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Skin abscess overlying the breast &ndash; Skin abscesses involving the skin overlying the breast abscesses are usually related to an infected epidermoid cyst or related to hidradenitis suppurativa. (See <a href=\"#H7390419\" class=\"local\">'Epidermoid cyst'</a> below and <a href=\"#H7390454\" class=\"local\">'Hidradenitis suppurativa'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Inflammatory breast cancer &ndash; Inflammatory breast cancer (IBC) should be considered if infection does not resolve with antimicrobial treatment. IBC may be distinguished by clinical manifestations of skin thickening due to edema, erythema, and peau d'orange appearance (<a href=\"image.htm?imageKey=PC%2F65383\" class=\"graphic graphic_picture graphicRef65383 \">picture 1</a> and <a href=\"image.htm?imageKey=ONC%2F70894\" class=\"graphic graphic_picture graphicRef70894 \">picture 2</a> and <a href=\"image.htm?imageKey=ONC%2F82220\" class=\"graphic graphic_picture graphicRef82220 \">picture 3</a>). It is often associated with axillary lymphadenopathy. The diagnosis is established via biopsy. (See <a href=\"topic.htm?path=inflammatory-breast-cancer-clinical-features-and-treatment\" class=\"medical medical_review\">&quot;Inflammatory breast cancer: Clinical features and treatment&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other breast malignancy &ndash; Comedo ductal carcinoma in situ can become infected and present with inflammation or an abscess [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/26\" class=\"abstract_t\">26</a>]. In addition, advanced breast cancer can present with skin ulceration, malodorous necrosis, and secondary infection. These diagnoses are established via biopsy. (See <a href=\"topic.htm?path=diagnostic-evaluation-of-women-with-suspected-breast-cancer\" class=\"medical medical_review\">&quot;Diagnostic evaluation of women with suspected breast cancer&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Paget disease of the breast &ndash; Paget disease of the breast (PDB) is a scaly, raw, vesicular, or ulcerated lesion that begins on the nipple and can spread to the areola (<a href=\"image.htm?imageKey=SURG%2F60575\" class=\"graphic graphic_picture graphicRef60575 \">picture 4</a>). The diagnosis is established by biopsy; the pathologic hallmark is the presence of malignant intraepithelial adenocarcinoma cells (Paget cells) within the epidermis of the nipple. Most cases are associated with an underlying invasive or noninvasive breast cancer. (See <a href=\"topic.htm?path=paget-disease-of-the-breast\" class=\"medical medical_review\">&quot;Paget disease of the breast&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Superficial thrombophlebitis of the breast &ndash; Superficial thrombophlebitis of the breast, also known as Mondor disease, is a self-limiting disease involving the superficial veins of the breast and anterior chest wall (<a href=\"image.htm?imageKey=SURG%2F64826\" class=\"graphic graphic_picture graphicRef64826 \">picture 5</a>) [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/27\" class=\"abstract_t\">27</a>]. Clinical manifestations include a thickened, tender cord with pain, erythema, and swelling; the syndrome can occur following surgery, core biopsy of the breast, radiation treatment, trauma, or unrelated to any antecedent event [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/28-33\" class=\"abstract_t\">28-33</a>]. The condition usually resolves in four to six weeks with symptomatic treatment using analgesics.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Morphea &ndash; Morphea (localized scleroderma) is an idiopathic inflammatory skin disorder associated with fibrosis (<a href=\"image.htm?imageKey=DERM%2F73769\" class=\"graphic graphic_picture graphicRef73769 \">picture 6</a>). It may be associated with radiation therapy, trauma, breast implants, or autoimmune disease [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/34\" class=\"abstract_t\">34</a>]. The initial sign of morphea is often abrupt onset of an erythematous patch or edematous plaque. Some patients may note pain or itching at the site prior to the development of a clinically evident lesion. Clinical manifestations include inflammation with hyperpigmentation, retraction, skin thickening, and fibrosis extending into the subcutaneous adipose tissue [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/35\" class=\"abstract_t\">35</a>]. (See <a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-morphea-localized-scleroderma-in-adults\" class=\"medical medical_review\">&quot;Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Postoperative dermal lymphedema &ndash; Postoperative dermal lymphedema presents with cutaneous erythema and induration in the absence of tenderness, fever, or leukocytosis [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/3,28,36\" class=\"abstract_t\">3,28,36</a>]. The breast involvement may be localized or diffuse. Lymphedema is a manifestation of lymphatic obstruction, which can occur following surgery alone or in conjunction with radiation treatment for breast cancer [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/37,38\" class=\"abstract_t\">37,38</a>]. Clinical evaluation and surveillance are adequate; a biopsy should be performed if malignancy is suspected.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Radiation-induced dermatitis &ndash; Clinical manifestations of radiation-induced dermatitis include erythema, edema, pigment changes, epilation, and dry or moist desquamation. These findings are strictly confined to the irradiated region and are not associated with fever or leukocytosis [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/28\" class=\"abstract_t\">28</a>]. The diagnosis is established based on clinical manifestations. (See <a href=\"topic.htm?path=radiation-dermatitis\" class=\"medical medical_review\">&quot;Radiation dermatitis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Radiation-induced fibrosis &ndash; Radiation-induced fibrosis can develop as a late effect of radiation treatment. Clinical manifestations include induration, thickening, and lymphedema in the skin and subcutaneous tissue of the breast. The diagnosis is established based on clinical manifestations. (See <a href=\"topic.htm?path=clinical-manifestations-prevention-and-treatment-of-radiation-induced-fibrosis\" class=\"medical medical_review\">&quot;Clinical manifestations, prevention, and treatment of radiation-induced fibrosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Spontaneous gangrene of the breast &ndash; Spontaneous gangrene of the breast with secondary infection can occur [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/15\" class=\"abstract_t\">15</a>]. This is very rare; risk factors include diabetes and renal failure (<a href=\"image.htm?imageKey=PC%2F80652\" class=\"graphic graphic_picture graphicRef80652 \">picture 7</a>). Spontaneous gangrene of the breast has also been reported in some patients within the first few days of receiving large doses of <a href=\"topic.htm?path=warfarin-drug-information\" class=\"drug drug_general\">warfarin</a> (<a href=\"image.htm?imageKey=PC%2F68120\" class=\"graphic graphic_picture graphicRef68120 \">picture 8</a>) [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/39\" class=\"abstract_t\">39</a>]. (See <a href=\"topic.htm?path=warfarin-and-other-vkas-dosing-and-adverse-effects#H39\" class=\"medical medical_review\">&quot;Warfarin and other VKAs: Dosing and adverse effects&quot;, section on 'Skin necrosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bite wound &ndash; Clinical manifestations of bite wound infections may include tenderness, erythema, swelling, purulent drainage, lymphangitis, and fever. Management of human bites includes wound care, antibiotic therapy, and tetanus vaccination. (See <a href=\"topic.htm?path=soft-tissue-infections-due-to-human-bites#H4\" class=\"medical medical_review\">&quot;Soft tissue infections due to human bites&quot;, section on 'Management'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H1315688\"><span class=\"h2\">Treatment</span></p><p class=\"headingAnchor\" id=\"H12088094\"><span class=\"h3\">Clinical approach</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Management of cellulitis includes symptomatic relief and antibiotic therapy. Nonsteroidal anti-inflammatory agents (eg, <a href=\"topic.htm?path=ibuprofen-drug-information\" class=\"drug drug_general\">ibuprofen</a>) along with cold compresses or ice packs reduce local pain and swelling.</p><p>Patient with uncomplicated cellulitis may be treated with oral <a href=\"topic.htm?path=dicloxacillin-drug-information\" class=\"drug drug_general\">dicloxacillin</a> (500 mg orally every six hours) or <a href=\"topic.htm?path=cephalexin-drug-information\" class=\"drug drug_general\">cephalexin</a> (500 mg orally every six hours). In the setting of immunoglobulin (Ig)E-mediated beta-lactam allergy, oral <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a> (300 mg to 450 orally every eight hours) may be administered. (See <a href=\"topic.htm?path=cellulitis-and-skin-abscess-in-adults-treatment\" class=\"medical medical_review\">&quot;Cellulitis and skin abscess in adults: Treatment&quot;</a>.)</p><p>Patients with signs of systemic toxicity or rapidly progressing erythema may be treated with <a href=\"topic.htm?path=oxacillin-drug-information\" class=\"drug drug_general\">oxacillin</a> (2 g intravenously every 6 hours) or <a href=\"topic.htm?path=cefazolin-drug-information\" class=\"drug drug_general\">cefazolin</a> (1 to 2 g intravenously every 8 hours). In the setting of IgE-mediated beta-lactam allergy, <a href=\"topic.htm?path=vancomycin-drug-information\" class=\"drug drug_general\">vancomycin</a> (15 to 20 <span class=\"nowrap\">mg/kg/dose</span> every 8 to 12 hours, not to exceed 2 g per dose) or <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a> (600 mg intravenously every 8 hours) may be administered. In the setting of risk for MRSA (<a href=\"image.htm?imageKey=ID%2F53504\" class=\"graphic graphic_table graphicRef53504 \">table 1</a>), vancomycin (15 to 20 <span class=\"nowrap\">mg/kg/dose</span> every 8 to 12 hours, not to exceed 2 g per dose) is warranted. (See <a href=\"topic.htm?path=methicillin-resistant-staphylococcus-aureus-mrsa-in-adults-treatment-of-skin-and-soft-tissue-infections\" class=\"medical medical_review\">&quot;Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Treatment of skin and soft tissue infections&quot;</a>.)</p><p>Once there is evidence of clinical improvement, treatment should be continued with oral therapy (<a href=\"topic.htm?path=dicloxacillin-drug-information\" class=\"drug drug_general\">dicloxacillin</a> 500 mg oral every six hours, <a href=\"topic.htm?path=cephalexin-drug-information\" class=\"drug drug_general\">cephalexin</a> 500 mg orally every six hours, or <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a> 300 to 450 mg orally every eight hours). Patients with MRSA may continue treatment with clindamycin, <a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-drug-information\" class=\"drug drug_general\">trimethoprim-sulfamethoxazole</a> (1 double-strength tab orally twice daily), or <a href=\"topic.htm?path=linezolid-drug-information\" class=\"drug drug_general\">linezolid</a> (600 mg orally twice daily) (<a href=\"image.htm?imageKey=ID%2F76937\" class=\"graphic graphic_table graphicRef76937 \">table 2</a>).</p><p>For patients who have received recent chemotherapy <span class=\"nowrap\">and/or</span> are neutropenic, the antibiotic regimen must be broadened to include coverage for aerobic gram-negative bacilli, including <em>Pseudomonas aeruginosa</em>. (See <a href=\"topic.htm?path=treatment-of-neutropenic-fever-syndromes-in-adults-with-hematologic-malignancies-and-hematopoietic-cell-transplant-recipients-high-risk-patients\" class=\"medical medical_review\">&quot;Treatment of neutropenic fever syndromes in adults with hematologic malignancies and hematopoietic cell transplant recipients (high-risk patients)&quot;</a>.)</p><p>The optimal duration of oral antibiotic therapy is uncertain; 5 to 14 days is appropriate for most patients, but the duration may be tailored based on individual clinical circumstances. Longer durations may be warranted in patients with breast cellulitis after breast-conserving surgery and radiotherapy. In general, antibiotics are continued until the clinical signs of infection have resolved, including pain, fever, erythema, and edema. Frequently, patients report improvement in pain before there is a noticeable decrease in erythema and swelling.</p><p>In the absence of clinical response to antibiotic therapy within 48 to 72 hours, ultrasound should be performed to assess for abscess. Alternative diagnoses such as inflammatory breast cancer should also be considered.</p><p class=\"headingAnchor\" id=\"H16336427\"><span class=\"h3\">Recurrent cellulitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with breast cellulitis are at risk for recurrent infection. The antibiotic management of a recurrent episode should be guided by microbiologic data obtained during a prior episode, if any. Otherwise, the choice of antibiotic therapy is the same as the approach to treatment of an initial episode of cellulitis (<a href=\"image.htm?imageKey=ID%2F76937\" class=\"graphic graphic_table graphicRef76937 \">table 2</a>). Chronic dermatologic conditions that predispose to cellulitis should be treated aggressively, and the skin should be kept as clean and dry as possible.</p><p>For some patients with multiple recurrent episodes, long-term suppressive antibiotic therapy may be appropriate. Management of these patients should be done in concert with infectious disease specialists or others with extensive expertise in the management of patients with breast cellulitis. Penicillin skin testing may be reasonable in patients with a history of penicillin allergy to determine if a beta-lactam can be used for long-term suppressive therapy. (See <a href=\"topic.htm?path=penicillin-skin-testing\" class=\"medical medical_review\">&quot;Penicillin skin testing&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H7390364\"><span class=\"h1\">SKIN DISORDERS OF THE BREAST</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some skin disorders of the breast may be associated with cellulitis [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/40\" class=\"abstract_t\">40</a>].</p><p class=\"headingAnchor\" id=\"H7390384\"><span class=\"h2\">Eczema</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Eczema is characterized by thickened skin, increased skin markings (lichenification), and excoriated and fibrotic papules. The diagnosis is established based on clinical manifestations. Patients with eczema involving the skin overlying the breast may develop secondary cellulitis (<a href=\"image.htm?imageKey=PC%2F50819\" class=\"graphic graphic_picture graphicRef50819 \">picture 9</a>). (See <a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H7390419\"><span class=\"h2\">Epidermoid cyst</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>An epidermoid cyst is a discrete, freely movable nodule. The diagnosis of epidermoid cyst is based upon clinical appearance and palpation. These cysts are common within the skin of the breast and can become secondarily infected (<a href=\"image.htm?imageKey=PC%2F66484\" class=\"graphic graphic_picture graphicRef66484 \">picture 10</a>). (See <a href=\"topic.htm?path=overview-of-benign-lesions-of-the-skin#H1101420445\" class=\"medical medical_review\">&quot;Overview of benign lesions of the skin&quot;, section on 'Epidermoid cyst'</a>.)</p><p class=\"headingAnchor\" id=\"H7390454\"><span class=\"h2\">Hidradenitis suppurativa</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hidradenitis suppurativa is a chronic inflammatory condition of the apocrine sweat glands; it can be associated with infection and abscess formation of the axilla or skin of the lower half of the breast (<a href=\"image.htm?imageKey=PC%2F64307\" class=\"graphic graphic_picture graphicRef64307 \">picture 11</a>) [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/15,26,41-44\" class=\"abstract_t\">15,26,41-44</a>]. Lesions frequently contain both aerobic and anaerobic bacteria. (See <a href=\"topic.htm?path=hidradenitis-suppurativa-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Hidradenitis suppurativa: Pathogenesis, clinical features, and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H7390603\"><span class=\"h2\">Intertrigo</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Intertrigo refers to inflammation at the site of two closely opposed skin surfaces (intertriginous area), often due to moisture and maceration (<a href=\"image.htm?imageKey=PC%2F65405\" class=\"graphic graphic_picture graphicRef65405 \">picture 12</a>) [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/45,46\" class=\"abstract_t\">45,46</a>]. The diagnosis is based on clinical manifestations. Intertrigo can be a recurrent problem in women with large ptotic breasts that make contact with the chest wall, usually affecting the skin of the lower half of the breast. (See <a href=\"topic.htm?path=candidal-intertrigo\" class=\"medical medical_review\">&quot;Candidal intertrigo&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H7390664\"><span class=\"h2\">Pilonidal sinus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A pilonidal sinus is a cavity in the skin with a narrow opening on the surface that contains hair and skin debris. Pilonidal sinuses affecting the nipple have been described in hairdressers and sheep shearers and occur as a result of small pieces of cut hair that accumulate in clothing and penetrate the skin, causing inflammation and infection [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/15,42,47-50\" class=\"abstract_t\">15,42,47-50</a>].</p><p class=\"headingAnchor\" id=\"H7390784\"><span class=\"h2\">Piercing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nipple rings can cause subareolar breast abscess and recurrent nipple infections, particularly in smokers (<a href=\"image.htm?imageKey=PC%2F63150\" class=\"graphic graphic_picture graphicRef63150 \">picture 13</a>) [<a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/51\" class=\"abstract_t\">51</a>]. In a study of 68 patients with a primary breast abscess, nipple piercing was a risk factor for a subareolar breast abscess (odds ratio [OR] 20, 95% CI 2.01-204.28) in addition to smoking (OR 11, 95% CI 4.41-29.94). (See <a href=\"topic.htm?path=body-piercing-in-adolescents-and-young-adults#H11\" class=\"medical medical_review\">&quot;Body piercing in adolescents and young adults&quot;, section on 'Localized infection'</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with breast cellulitis present with a tender, warm, erythematous, and edematous breast. (See <a href=\"#H12681954\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beta-hemolytic <em>Streptococcus </em>is an important cause of breast cellulitis. <em>Staphylococcus aureus</em>, including methicillin-resistant <em>S. aureus</em>, can also be an important pathogen. (See <a href=\"#H7047054\" class=\"local\">'Microbiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with uncomplicated breast cellulitis may be treated with empiric oral antibiotic therapy. Patients with signs of systemic toxicity or rapidly progressing erythema should be treated with parenteral antibiotics. In the absence of clinical response to antibiotic therapy within 48 to 72 hours, ultrasound should be performed to assess for abscess. Alternative diagnoses such as inflammatory breast cancer should also be considered. Duration of therapy is usually 5 to 14 days, depending on response to treatment. (See <a href=\"#H12088094\" class=\"local\">'Clinical approach'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment of recurrent cellulitis should be guided by microbiologic data (if available). Otherwise, the approach to antibiotic selection is the same as for an initial episode of cellulitis. Chronic dermatologic conditions that predispose to cellulitis should be treated aggressively, and the skin of the lower breast should be kept as clean and dry as possible. (See <a href=\"#H16336427\" class=\"local\">'Recurrent cellulitis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Some skin disorders of the breast may be associated with cellulitis. (See <a href=\"#H7390364\" class=\"local\">'Skin disorders of the breast'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/1\" class=\"nounderline abstract_t\">Froman J, Landercasper J, Ellis R, et al. Red breast as a presenting complaint at a breast center: an institutional review. Surgery 2011; 149:813.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/2\" class=\"nounderline abstract_t\">Hughes LL, Styblo TM, Thoms WW, et al. Cellulitis of the breast as a complication of breast-conserving surgery and irradiation. Am J Clin Oncol 1997; 20:338.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/3\" class=\"nounderline abstract_t\">Mertz KR, Baddour LM, Bell JL, Gwin JL. Breast cellulitis following breast conservation therapy: a novel complication of medical progress. Clin Infect Dis 1998; 26:481.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/4\" class=\"nounderline abstract_t\">Indelicato DJ, Grobmyer SR, Newlin H, et al. Delayed breast cellulitis: an evolving complication of breast conservation. Int J Radiat Oncol Biol Phys 2006; 66:1339.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/5\" class=\"nounderline abstract_t\">Brewer VH, Hahn KA, Rohrbach BW, et al. Risk factor analysis for breast cellulitis complicating breast conservation therapy. Clin Infect Dis 2000; 31:654.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/6\" class=\"nounderline abstract_t\">Zippel D, Siegelmann-Danieli N, Ayalon S, et al. Delayed breast cellulitis following breast conserving operation. Eur J Surg Oncol 2003; 29:327.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/7\" class=\"nounderline abstract_t\">Baddour LM. Breast cellulitis complicating breast conservation therapy. J Intern Med 1999; 245:5.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/8\" class=\"nounderline abstract_t\">Miller SR, Mondry T, Reed JS, et al. Delayed cellulitis associated with conservative therapy for breast cancer. J Surg Oncol 1998; 67:242.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/9\" class=\"nounderline abstract_t\">Rescigno J, McCormick B, Brown AE, Myskowski PL. Breast cellulitis after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1994; 29:163.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/10\" class=\"nounderline abstract_t\">Simon MS, Cody RL. Cellulitis after axillary lymph node dissection for carcinoma of the breast. Am J Med 1992; 93:543.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/11\" class=\"nounderline abstract_t\">Baddour LM, Bisno AL. Non-group A beta-hemolytic streptococcal cellulitis. Association with venous and lymphatic compromise. Am J Med 1985; 79:155.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/12\" class=\"nounderline abstract_t\">Jackson LA, Hilsdon R, Farley MM, et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med 1995; 123:415.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/13\" class=\"nounderline abstract_t\">Peltecu G. Images in clinical medicine. Cellulitis after treatment for breast cancer. N Engl J Med 2007; 357:488.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/14\" class=\"nounderline abstract_t\">Staren ED, Klepac S, Smith AP, et al. The dilemma of delayed cellulitis after breast conservation therapy. Arch Surg 1996; 131:651.</a></li><li class=\"breakAll\">Dixon JM. Breast infection. In: ABC of Breast Diseases, Dixon JM (Ed), Blackwell Publishing, Oxford 2006. p.19.</li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/16\" class=\"nounderline abstract_t\">Foxman B, D'Arcy H, Gillespie B, et al. Lactation mastitis: occurrence and medical management among 946 breastfeeding women in the United States. Am J Epidemiol 2002; 155:103.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/17\" class=\"nounderline abstract_t\">Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects. Obstet Gynecol 2007; 109:479.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/18\" class=\"nounderline abstract_t\">Stafford I, Hernandez J, Laibl V, et al. Community-acquired methicillin-resistant Staphylococcus aureus among patients with puerperal mastitis requiring hospitalization. Obstet Gynecol 2008; 112:533.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/19\" class=\"nounderline abstract_t\">Jahanfar S, Ng CJ, Teng CL. Antibiotics for mastitis in breastfeeding women. Cochrane Database Syst Rev 2009; :CD005458.</a></li><li class=\"breakAll\">Hale TW, Berens PD. Clinical Therapy in Breastfeeding Patients, 2nd ed, Pharmasoft, Amarillo 2002.</li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/21\" class=\"nounderline abstract_t\">Peters F, Petersen EE, Kirkpatrick CJ. Isolated erythema (cellulitis) of the breast. Breast 2002; 11:484.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/22\" class=\"nounderline abstract_t\">Rahmouni A, Chosidow O, Mathieu D, et al. MR imaging in acute infectious cellulitis. Radiology 1994; 192:493.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/23\" class=\"nounderline abstract_t\">Vitug AF, Newman LA. Complications in breast surgery. Surg Clin North Am 2007; 87:431.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/24\" class=\"nounderline abstract_t\">Throckmorton AD, Boughey JC, Boostrom SY, et al. Postoperative prophylactic antibiotics and surgical site infection rates in breast surgery patients. Ann Surg Oncol 2009; 16:2464.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/25\" class=\"nounderline abstract_t\">McNeely ML, Binkley JM, Pusic AL, et al. A prospective model of care for breast cancer rehabilitation: postoperative and postreconstructive issues. Cancer 2012; 118:2226.</a></li><li class=\"breakAll\">Dixon JM, Bundred NJ. Management of disorders of the ductal system and infections. In: Diseases of the Breast, Harris JR, Lippman ME, Morrow M, Osborne CK (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2004. p.47.</li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/27\" class=\"nounderline abstract_t\">Becker L, McCurdy LI, Taves DH. Superficial thrombophlebitis of the breast (Mondor's disease). Can Assoc Radiol J 2001; 52:193.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/28\" class=\"nounderline abstract_t\">Milgrom S, Higgins SA. Management of cellulitis associated with treatment of breast cancer. J Support Oncol 2009; 7:174.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/29\" class=\"nounderline abstract_t\">Catania S, Zurrida S, Veronesi P, et al. Mondor's disease and breast cancer. Cancer 1992; 69:2267.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/30\" class=\"nounderline abstract_t\">Shetty MK, Watson AB. Mondor's disease of the breast: sonographic and mammographic findings. AJR Am J Roentgenol 2001; 177:893.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/31\" class=\"nounderline abstract_t\">Yanik B, Conkbayir I, Oner O, Hekimo&#287;lu B. Imaging findings in Mondor's disease. J Clin Ultrasound 2003; 31:103.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/32\" class=\"nounderline abstract_t\">Pasta V, D'Orazi V, Sottile D, et al. Breast Mondor's disease: Diagnosis and management of six new cases of this underestimated pathology. Phlebology 2015; 30:564.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/33\" class=\"nounderline abstract_t\">Laroche JP, Galanaud J, Labau D, et al. Mondor's disease: what's new since 1939? Thromb Res 2012; 130 Suppl 1:S56.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/34\" class=\"nounderline abstract_t\">Clark CJ, Wechter D. Morphea of the breast--an uncommon cause of breast erythema. Am J Surg 2010; 200:173.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/35\" class=\"nounderline abstract_t\">Dubner S, Bovi J, White J, Susnik B. Postirradiation morphea in a breast cancer patient. Breast J 2006; 12:173.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/36\" class=\"nounderline abstract_t\">King R, Duncan L, Shupp DL, Googe PB. Postsurgical dermal lymphedema clinically mimicking inflammatory breast carcinoma. Arch Dermatol 2001; 137:969.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/37\" class=\"nounderline abstract_t\">Browse NL, Stewart G. Lymphoedema: pathophysiology and classification. J Cardiovasc Surg (Torino) 1985; 26:91.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/38\" class=\"nounderline abstract_t\">Marcks P. Lymphedema. Pathogenesis, prevention, and treatment. Cancer Pract 1997; 5:32.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/39\" class=\"nounderline abstract_t\">Bauer KA. Coumarin-induced skin necrosis. Arch Dermatol 1993; 129:766.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/40\" class=\"nounderline abstract_t\">Dixon JM, Khan LR. Treatment of breast infection. BMJ 2011; 342:d396.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/41\" class=\"nounderline abstract_t\">Attar KH, Waghorn D, Lyons M, Cunnick G. Rare species of actinomyces as causative pathogens in breast abscess. Breast J 2007; 13:501.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/42\" class=\"nounderline abstract_t\">Dixon JM. Breast abscess. Br J Hosp Med (Lond) 2007; 68:315.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/43\" class=\"nounderline abstract_t\">Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009; 60:539.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/44\" class=\"nounderline abstract_t\">Buimer MG, Wobbes T, Klinkenbijl JH. Hidradenitis suppurativa. Br J Surg 2009; 96:350.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/45\" class=\"nounderline abstract_t\">Janniger CK, Schwartz RA, Szepietowski JC, Reich A. Intertrigo and common secondary skin infections. Am Fam Physician 2005; 72:833.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/46\" class=\"nounderline abstract_t\">Mistiaen P, Poot E, Hickox S, et al. Preventing and treating intertrigo in the large skin folds of adults: a literature overview. Dermatol Nurs 2004; 16:43.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/47\" class=\"nounderline abstract_t\">Gannon MX, Crowson MC, Fielding JW. Periareolar pilonidal abscesses in a hairdresser. BMJ 1988; 297:1641.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/48\" class=\"nounderline abstract_t\">Banerjee A. Pilonidal sinus of nipple in a canine beautician. BMJ 1985; 291:1787.</a></li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/49\" class=\"nounderline abstract_t\">Bowers PW. Roustabouts' and barbers' breast. Clin Exp Dermatol 1982; 7:445.</a></li><li class=\"breakAll\">Dixon JM. Benign breast disease. In: The New Airds Companion to Surgical Studies, Burnand KG, Young AE (Eds), Churchill Livingstone, Edinburgh 1992. p.811.</li><li><a href=\"https://www.uptodate.com/contents/breast-cellulitis-and-other-skin-disorders-of-the-breast/abstract/51\" class=\"nounderline abstract_t\">Gollapalli V, Liao J, Dudakovic A, et al. Risk factors for development and recurrence of primary breast abscesses. J Am Coll Surg 2010; 211:41.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 797 Version 17.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H11\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H7390833\" id=\"outline-link-H7390833\">BREAST CELLULITIS</a><ul><li><a href=\"#H3786583\" id=\"outline-link-H3786583\">Epidemiology</a></li><li><a href=\"#H7047054\" id=\"outline-link-H7047054\">Microbiology</a></li><li><a href=\"#H12681954\" id=\"outline-link-H12681954\">Clinical manifestations</a></li><li><a href=\"#H22190971\" id=\"outline-link-H22190971\">Diagnosis</a></li><li><a href=\"#H3786712\" id=\"outline-link-H3786712\">Differential diagnosis</a></li><li><a href=\"#H1315688\" id=\"outline-link-H1315688\">Treatment</a><ul><li><a href=\"#H12088094\" id=\"outline-link-H12088094\">- Clinical approach</a></li><li><a href=\"#H16336427\" id=\"outline-link-H16336427\">- Recurrent cellulitis</a></li></ul></li></ul></li><li><a href=\"#H7390364\" id=\"outline-link-H7390364\">SKIN DISORDERS OF THE BREAST</a><ul><li><a href=\"#H7390384\" id=\"outline-link-H7390384\">Eczema</a></li><li><a href=\"#H7390419\" id=\"outline-link-H7390419\">Epidermoid cyst</a></li><li><a href=\"#H7390454\" id=\"outline-link-H7390454\">Hidradenitis suppurativa</a></li><li><a href=\"#H7390603\" id=\"outline-link-H7390603\">Intertrigo</a></li><li><a href=\"#H7390664\" id=\"outline-link-H7390664\">Pilonidal sinus</a></li><li><a href=\"#H7390784\" id=\"outline-link-H7390784\">Piercing</a></li></ul></li><li><a href=\"#H11\" id=\"outline-link-H11\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/797|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PC/65383\" class=\"graphic graphic_picture\">- Inflammatory breast cancer</a></li><li><a href=\"image.htm?imageKey=ONC/70894\" class=\"graphic graphic_picture\">- Inflammatory breast cancer with peau d orange appearance</a></li><li><a href=\"image.htm?imageKey=ONC/82220\" class=\"graphic graphic_picture\">- Inflammatory breast cancer appearance </a></li><li><a href=\"image.htm?imageKey=SURG/60575\" class=\"graphic graphic_picture\">- Paget disease of the breast presentation</a></li><li><a href=\"image.htm?imageKey=SURG/64826\" class=\"graphic graphic_picture\">- Mondor disease of the breast</a></li><li><a href=\"image.htm?imageKey=DERM/73769\" class=\"graphic graphic_picture\">- Circumscribed morphea - inflammatory plaque</a></li><li><a href=\"image.htm?imageKey=PC/80652\" class=\"graphic graphic_picture\">- Gangrene of breast</a></li><li><a href=\"image.htm?imageKey=PC/68120\" class=\"graphic graphic_picture\">- TB breast</a></li><li><a href=\"image.htm?imageKey=PC/50819\" class=\"graphic graphic_picture\">- Recurrent cellulitis</a></li><li><a href=\"image.htm?imageKey=PC/66484\" class=\"graphic graphic_picture\">- Skin abscess from epidermal inclusion cyst</a></li><li><a href=\"image.htm?imageKey=PC/64307\" class=\"graphic graphic_picture\">- Hidradenitis suppurativa of the breast and axilla</a></li><li><a href=\"image.htm?imageKey=PC/65405\" class=\"graphic graphic_picture\">- Intertrigo</a></li><li><a href=\"image.htm?imageKey=PC/63150\" class=\"graphic graphic_picture\">- Periductal mastitis piercing</a></li></ul></li><li><div id=\"ID/797|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/53504\" class=\"graphic graphic_table\">- Risk factors for MRSA colonization</a></li><li><a href=\"image.htm?imageKey=ID/76937\" class=\"graphic graphic_table\">- Empiric oral treatment for MRSA and beta-hemolytic streptococci</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=body-piercing-in-adolescents-and-young-adults\" class=\"medical medical_review\">Body piercing in adolescents and young adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=candidal-intertrigo\" class=\"medical medical_review\">Candidal intertrigo</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cellulitis-and-skin-abscess-in-adults-treatment\" class=\"medical medical_review\">Cellulitis and skin abscess in adults: Treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-prevention-and-treatment-of-radiation-induced-fibrosis\" class=\"medical medical_review\">Clinical manifestations, prevention, and treatment of radiation-induced fibrosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-evaluation-of-women-with-suspected-breast-cancer\" class=\"medical medical_review\">Diagnostic evaluation of women with suspected breast cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hidradenitis-suppurativa-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">Hidradenitis suppurativa: Pathogenesis, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=inflammatory-breast-cancer-clinical-features-and-treatment\" class=\"medical medical_review\">Inflammatory breast cancer: Clinical features and treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lactational-mastitis\" class=\"medical medical_review\">Lactational mastitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=methicillin-resistant-staphylococcus-aureus-mrsa-in-adults-treatment-of-skin-and-soft-tissue-infections\" class=\"medical medical_review\">Methicillin-resistant Staphylococcus aureus (MRSA) in adults: Treatment of skin and soft tissue infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-benign-lesions-of-the-skin\" class=\"medical medical_review\">Overview of benign lesions of the skin</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-breast-reconstruction\" class=\"medical medical_review\">Overview of breast reconstruction</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=paget-disease-of-the-breast\" class=\"medical medical_review\">Paget disease of the breast</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-morphea-localized-scleroderma-in-adults\" class=\"medical medical_review\">Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=penicillin-skin-testing\" class=\"medical medical_review\">Penicillin skin testing</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-breast-abscess\" class=\"medical medical_review\">Primary breast abscess</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=radiation-dermatitis\" class=\"medical medical_review\">Radiation dermatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=soft-tissue-infections-due-to-human-bites\" class=\"medical medical_review\">Soft tissue infections due to human bites</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-neutropenic-fever-syndromes-in-adults-with-hematologic-malignancies-and-hematopoietic-cell-transplant-recipients-high-risk-patients\" class=\"medical medical_review\">Treatment of neutropenic fever syndromes in adults with hematologic malignancies and hematopoietic cell transplant recipients (high-risk patients)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=warfarin-and-other-vkas-dosing-and-adverse-effects\" class=\"medical medical_review\">Warfarin and other VKAs: Dosing and adverse effects</a></li></ul></div></div>","javascript":null}